HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cao Xie Selected Research

RGD-poly(ethylene glycol)-SS-polyethylenimine

8/2013Glutathione-sensitive RGD-poly(ethylene glycol)-SS-polyethylenimine for intracranial glioblastoma targeted gene delivery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cao Xie Research Topics

Disease

33Neoplasms (Cancer)
01/2022 - 05/2009
24Glioma (Gliomas)
01/2022 - 12/2013
14Glioblastoma (Glioblastoma Multiforme)
01/2022 - 04/2010
11Brain Neoplasms (Brain Tumor)
01/2022 - 07/2011
3Fibrosis (Cirrhosis)
12/2021 - 09/2011
3Liver Cirrhosis (Hepatic Cirrhosis)
12/2021 - 07/2010
2Central Nervous System Diseases (CNS Diseases)
11/2021 - 12/2010
2Adenocarcinoma
10/2020 - 08/2015
2Hemolysis
07/2019 - 04/2016
1Breast Neoplasms (Breast Cancer)
01/2022
1Triple Negative Breast Neoplasms
01/2022
1Circulating Neoplastic Cells
01/2022
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2021
1Brain Diseases (Brain Disorder)
11/2021
1Atherosclerosis
11/2021
1Residual Neoplasm
10/2021
1Hypothermia
01/2021
1Thrombosis (Thrombus)
12/2020
1Retinoblastoma (Glioblastoma, Retinal)
11/2019
1Neoplasm Metastasis (Metastasis)
10/2017

Drug/Important Bio-Agent (IBA)

23Peptides (Polypeptides)IBA
01/2022 - 01/2012
20Pharmaceutical PreparationsIBA
01/2022 - 05/2009
16LigandsIBA
01/2022 - 01/2013
16MicellesIBA
01/2020 - 05/2009
15Liposomes (Liposome)IBA
01/2022 - 01/2012
10Paclitaxel (Taxol)FDA LinkGeneric
01/2020 - 04/2010
9Doxorubicin (Adriamycin)FDA LinkGeneric
10/2020 - 01/2013
8Proteins (Proteins, Gene)FDA Link
01/2022 - 09/2005
7Neuropilin-1IBA
09/2018 - 10/2013
5IntegrinsIBA
01/2021 - 09/2011
5monomethoxypolyethylene glycol (MPEG)IBA
06/2015 - 05/2009
4polypeptide CIBA
01/2021 - 04/2010
3Endoplasmic Reticulum Chaperone BiPIBA
01/2022 - 10/2017
3Biological ProductsIBA
12/2021 - 02/2014
3Temozolomide (Temodar)FDA LinkGeneric
10/2021 - 11/2015
3monomethoxypolyethyleneglycol- polylactide block copolymerIBA
01/2020 - 04/2010
3Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2018 - 06/2016
3cyclic arginine-glycine-aspartic acid peptideIBA
09/2017 - 04/2010
3PolyethyleneimineIBA
08/2015 - 12/2013
3poly(ethylene glycol)-co-poly(ethyleneimine)IBA
08/2015 - 12/2013
31,2-distearoylphosphatidylethanolamine (DSPE)IBA
06/2015 - 05/2009
3Ethylene Glycol (Monoethylene Glycol)IBA
06/2015 - 04/2010
3polyethylene glycol- distearoylphosphatidylethanolamineIBA
10/2014 - 05/2009
2Therapeutic UsesIBA
01/2022 - 10/2013
2cabazitaxelFDA Link
01/2022 - 01/2022
2GadoliniumIBA
12/2021 - 04/2015
2Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
12/2021 - 04/2012
2GemcitabineFDA Link
12/2021 - 09/2018
2Carbon Tetrachloride (Tetrachloromethane)IBA
12/2021 - 09/2011
2LipidsIBA
11/2021 - 04/2016
2Small Interfering RNA (siRNA)IBA
10/2021 - 11/2019
2AntibodiesIBA
01/2021 - 10/2020
2PolymersIBA
10/2020 - 05/2009
2phenolic acidIBA
10/2020 - 09/2017
2GlycopeptidesIBA
07/2019 - 01/2018
2Melitten (Melittin)IBA
07/2019 - 04/2016
2Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA
10/2018 - 01/2018
2ErbB Receptors (EGF Receptor)IBA
07/2017 - 01/2015
2Tumor Suppressor Protein p53IBA
11/2015 - 04/2012
2Folic Acid (Vitamin M)FDA LinkGeneric
01/2014 - 05/2009
2Thioacetamide (Thioacetamid)IBA
04/2012 - 09/2011
2Antineoplastic Agents (Antineoplastics)IBA
01/2012 - 05/2009
1Protein CoronaIBA
01/2022
1apolipoprotein A-IV (apolipoprotein AIV)IBA
01/2022
1Membrane LipidsIBA
01/2022
1Transferrin (beta 2 Transferrin)IBA
01/2022
1ApolipoproteinsIBA
01/2022
1Blood Proteins (Serum Proteins)IBA
01/2022
1Platelet-Derived Growth FactorIBA
12/2021
1MitogensIBA
12/2021
1Cyclic PeptidesIBA
12/2021
1trimethyloxamine (trimethylamine N-oxide)IBA
11/2021
1HydrogelsIBA
10/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1Adenosine Triphosphate (ATP)IBA
01/2021
1Complement System Proteins (Complement)IBA
01/2021
1Immunoglobulin G (IgG)IBA
01/2021
1Immunoglobulin M (IgM)IBA
01/2021
1Complement Membrane Attack Complex (Membrane Attack Complex)IBA
01/2021
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2021
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2021
1lumbrokinaseIBA
12/2020
12-aminoimidazoleIBA
10/2020
1Immune Checkpoint InhibitorsIBA
10/2020
1parthenolideIBA
01/2020
1Evans Blue (Blue, Evans)FDA Link
09/2018
1Nucleic AcidsIBA
01/2018
1BradykininIBA
01/2018
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2018
1AmidesIBA
01/2018
1Dopamine Receptors (Dopamine Receptor)IBA
09/2017
1epidermal growth factor receptor VIIIIBA
07/2017
1HydrocarbonsIBA
05/2017
1arginyl-glycyl-aspartic acidIBA
05/2017
1Drug CarriersIBA
04/2016

Therapy/Procedure

19Therapeutics
01/2022 - 05/2010
6Drug Therapy (Chemotherapy)
01/2022 - 06/2015
5Intravenous Administration
10/2020 - 04/2010
1Precision Medicine
01/2018
1Intravenous Injections
01/2016